Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania

Effect of Coadministered Fat on the Tolerability, Safety, and Pharmacokinetic Properties of Dihydroartemisinin-Piperaquine in Papua New Guinean Children with Uncomplicated Malaria

(2014) B. R. Moore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Profile of Adverse Events in Patients Receiving Treatment for Malaria in Urban Ghana: A Cohort-Event Monitoring Study

(2014) Alexander N. O. Dodoo et al.   DRUG SAFETY

Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance

(2013) Khadime Sylla et al.   BMC INFECTIOUS DISEASES

Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study

(2013) Peter Usman Bassi et al.   DRUG SAFETY

Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting

(2013) Sylla Thiam et al.   MALARIA JOURNAL

MMV in partnership: the Eurartesim® experience

(2013) David Ubben et al.   MALARIA JOURNAL

In VitroCardiovascular Effects of Dihydroartemisin-Piperaquine Combination Compared with Other Antimalarials

(2012) Franco Borsini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies

(2011) R. Thertulien et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring

(2011) Andrea Kuemmerle et al.   MALARIA JOURNAL

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children

(2011) Michael Nambozi et al.   MALARIA JOURNAL

Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties

(2011) Nicola Gargano et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana

(2010) Dominic B Dery et al.   MALARIA JOURNAL

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting

(2010) Abdunoor M Kabanywanyi et al.   MALARIA JOURNAL

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia

(2010) Neena Valecha et al.   PLoS One

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

(2009) Quique Bassat et al.   PLoS One